Tobacco Reporter’s December 2022 issue explores the outlook for flavors, both in vaping products and traditional cigarettes. How will the proliferation of flavor bans impact consumption, the industry and ultimately public health? In three separate articles, Clive Bates, Cheryl Olson and Stefanie Rossel examine the issue from different angles.
George Gay looks at the new challenges and opportunities facing Altria Group in the wake of its new partnership with Japan Tobacco International. Stefanie spoke with leading cigarette manufacturers about their efforts to cultivate startups with technologies that may aid the industry’s transition beyond tobacco and nicotine.
Timothy Donahue provides a peek behind the curtain at Smoore, the company behind many of the products that survived the U.S. Food and Drug Administration’s brutal vetting process. And Ivan Genov reports from the International Tobacco Growers’ annual general meeting in Portugal.
Also in this issue: An exclusive report from Iran, where illicit cigarettes continue to elbow out legitimate sales.
In Tobacco Reporter’s November 2022 issue, we look back on another successful GTNF. Under the theme “Accessing Innovation,” the conference debated, among many other topics, the challenges and opportunities for tobacco harm reduction.
While technological breakthroughs have made it possible to develop nicotine products that present a fraction of the health risks presented by combustible cigarettes, such products remain inaccessible to consumers in many markets due to a combination of underinvestment and ill-conceived regulation.
George Gay evaluates the latest Tobacco Transformation Index and questions to what extent the valuable information in the report will accelerate tobacco harm reduction worldwide. Cheryl Olson explores the role of consumer choice and Stefanie Rossel reports from Spain, where proposed legislation threatens to kill the independent vaping sector.
Also in this issue, we reveal the winners of the 2022 Golden Leaf Awards.
Tobacco Reporter’s October 2022 issue explores the ‘pharmaceuticalization’ of tobacco. Confronted with stagnant sales in their traditional business, cigarette companies have been looking not only past tobacco but also past nicotine, identifying new areas to leverage their specialist knowledge of, say, plant genomes, lung physiology or substance delivery.
Perhaps surprisingly, the field to which such skills are particularly well suited is the pharmaceutical business. Accordingly, we’ve seen tobacco companies invest in vaccines and medical devices, such as lung treatments.
While these efforts have provoked their share of criticism from anti-smoking campaigners, they also hold considerable promise. As Clive Bates and Cheryl Olson point out in separate articles this month, tobacco’s involvement in the pharmaceutical business could very well be a net positive for public health.
Other stories in this issue cover Zimbabwe’s tottering effort to diversify into cannabis production, the generational endgame bills in New Zealand and Malaysia, and paper manufacturers’ heroic attempts to reduce the environmental impact of their energy-hungry operations.
We also profile Kaival Brands, a company that has been making remarkable inroads into the global vapor market.
Tobacco Reporter’s September 2022 issue looks ahead at the GTNF, which will take place Sept. 27-29 in Washington DC.
In line with this year’s event’s “accessing innovation” theme, Clive Bates makes a compelling case for rendering combustible cigarettes obsolete through creative destruction. Innovation offers an extraordinarily effective tool to help reduce the health impact of smoking, argues Bates—provided that it is given a chance.
Cheryl Olson provides a sneak peek at her GTNF panel, which will focus on “forgotten smokers,” whose views are routinely neglected by policymakers, physicians and other potential sources of support. Panelists will share personal experiences and research on ways to raise empathy and visibility for people who smoke and ideas to spread the benefits of harm reduction more equitably.
Also in this issue: A profile of biodegradable filter manufacturer McAirlaid’s and a story about Moldova’s fight against the illicit cigarette trade.
In Tobacco Reporter’s August 2022 issue we examine the impact of the war in Ukraine on the tobacco industry. What has the conflict meant for cigarette production, distribution and consumption? And how are the multinationals making good on their commitment to extract themselves from the Russian market?
Clive Bates urges a rethink of nicotine policies now that the legal recreational drug is available with minimal harm to health, and George Gay reports from Forest’s summer event in London, where speakers lament the continuing assaults on personal choice and personal responsibility.
Stefanie Rossel describes a groundbreaking technology from Sweden that allows tobacco companies to control the dose of nicotine released from pouches, and Tim Donahue has the latest on Universal’s sustainability initiatives.
Also in this issue: a report on the market for tobacco-related instrumentation.
In it July 2022 issue, Tobacco Reporter examines the U.S. plan to mandate significant reductions in the nicotine levels of cigarettes, which the Biden administration made official on June 21.
Will the measure prevent future generations from becoming addicted to cigarettes and prompt current smokers to quit, as its proponents contend, or will it cause nicotine users to smoke more cigarettes to get their fix—and thus inhale more toxins—as critics have suggested?
Cheryl Olson reports from the E-Cigarette Summit in Washington, where speakers reminded their audience that, contrary to what certain academics believe, smokers still exist in persistently large numbers, many in marginalized pockets of society.
Also in the issue: A profile of Hail and Cotton, which recently celebrated its 100th anniversary and an update on KT&G’s progress toward achieving its ambition of becoming a global top tier nicotine business.
In Tobacco Reporter’s June 2022 issue, Clive Bates takes the retirement of FDA Center of Tobacco Products Director Mitch Zeller as an opportunity to reflect on what authorities worldwide can learn from the United States’ experience in regulating nicotine products. Which practices are worth replicating? Which are best avoided?
John Pritchard details 22nd Century Group’s plans in the wake of its VLN modified-risk tobacco product marketing order and in the context of the FDA’s plans to mandate lower nicotine levels.
International Tobacco Growers Association CEO Mercedes Vasquez and her predecessor, Antonio Abrunhosa, speak about the plight of farmers in a world of declining demand and increasing compliance requirements.
Roya Ghafale of Oxfirst explains why the tobacco industry should start thinking more creatively about intellectual property.
Tobacco Reporter’s May 2022 issue looks at industry efforts to improve the sustainability of its operations—to ensure today’s stakeholders can meet current needs without compromising the needs of future generations.
Among other topics, we examine industry initiatives to reduce battery waste generated by electronic nicotine delivery products, machinery makers’ efforts to minimize their equipment’s energy consumption and vapor companies’ endeavors to include more recyclable components in their products.
Our May issue also highlights a remarkable new technology that allows cigarette manufacturers to capture the carbon dioxide generated by their operations and use it for tobacco expansion, thus reducing greenhouse gas emissions and expenses simultaneously!
Clive Bates explains why criticism of the tobacco industry’s diversification is misguided and Cheryl Olson explores ways to educate physicians on nicotine and the risk continuum.
From plant-based vaccines through revolutionary vaping hardware to therapeutic devices, the tobacco industry is innovating at an unprecedented pace. In the process, it is not only reducing the harm of tobacco consumption, but also moving beyond its traditional mission of providing pleasure, investing in new areas, such as medical devices.
If the sector continues on its current trajectory—and if its initiatives are not stubbed out by counterproductive regulations and kneejerk hostility—the industry once associated with disease could one day become a net contributor to public health.
While there admittedly is a long way to go for that vision to become reality, the first steps into a radically different future are being taken as you read these words. We believe the impact of these changes could be so profound that it justifies an entire issue.
Read our April edition and marvel at the shape, pace and significance of this remarkable transformation.
Tobacco Reporter’s March 2022 issue evaluates the fallout from South Africa’s ill-conceived ban on tobacco sales during the country’s 2020 Covid-19 lockdown. Eighteen months after the ban ended, illicit cigarettes still account for a whopping 60 percent of the domestic market. As South African Revenue Service Commissioner Edward Kieswetter predicted, the country continues to struggle with the corruption and illegal activities that took root in those four calamitous months.
Meanwhile, halfway around the world, U.S. vape shops and tobacco outlets are facing a spike in robberies, which critics attribute at least in part to regulatory actions, such as tax increases, flavor bans and higher minimum age requirements. As Richard Marianos, a veteran of the Bureau of Alcohol, Tobacco, Firearms and Explosives, observes, crime is often an unintended and overlooked consequence of regulatory constraints on the marketplace.
Cheryl Olson writes about the pitfalls the industry faces when discussing harm reduction; Stefanie Rossel examines the state of the filter market and George Gay reports on the latest developments in the ongoing battle against tobacco insect infestations.
Tobacco Reporter’s February 2022 issue examines the latest developments relating to tipping paper, including technologies to differentiate products and solutions to ventilate tobacco smoke.
Clive Bates tackles the twin evils of prohibition and illicit trade while Cheryl Olson discusses the U.S. Food and Drug Administration’s emphasis on nicotine. Is such a focus appropriate for the protection of public health?
Timothy Donahue profiles Turning Point Brands, which has ventured into new products by taking calculated risks.
George Gay dissects the contrast between the small companies that stood at the cradle of the vapor revolution but are increasingly unable to comply with mounting regulatory requirements and the big heritage tobacco companies that joined the movement later but are more likely to survive due to their considerable resources.
Stefanie Rossel highlights the pending legalization of recreational cannabis in Germany and what it might mean for the tobacco business.
Tobacco Reporter’s January 2022 issue examines the lingering impact of the Covid-19 pandemic on the global supply chain. Uneven economic recoveries, among other factors, have caused containers to pile up in places that don’t need them, while leaving exporters scrambling for vessels to ship their products. With fewer ships plying the high seas, transportation costs have skyrocketed, and freight forwarders are passing their expenses on to customers.
Cheryl Olson and Willie McKinney write about the importance of understanding how regulators perceive your business. As it turns out, regulators views can be quite different from how nicotine companies perceive themselves.
Simon Clark, director of the smokers’ rights group Forest, reminds us that many smokers enjoy smoking and have no wish to quit—a fact that is often overlooked as companies compete to “unsmoke” the world.
We also highlight a company that has been making extraordinary inroads in the heat-not-burn segment. With its “zero cleaning” consumables, Poda Holdings believes it has solved one of the main pain points in tobacco-heating technology.
Also in this issue: A report from the International Tobacco Growers Association’s recent “issues day,” and a look at Zimbabwe’s efforts to reverse tobacco curing-related deforestation.
Tobacco Reporter’s December 2021 issue highlights synthetic nicotine, which has gained popularity among U.S. e-cigarette manufacturers as the Food and Drug Administration buried the vapor business in marketing denial orders. Is synthetic nicotine a legitimate alternative to the naturally derived variety, or does it represent a loophole? Cheryl Olson and Willie McKinney share their thoughts on the controversy.
George Gay reflects on the recently concluded ninth Conference of the Parties to the World Health Organization’s Framework Convention on Tobacco Control and Clive Bates describes the two camps in tobacco control—transformers and abolitionists.
Also in this issue: a look at the Medical Dictionary for Regulatory Activities, which helps evaluators describe the health effects of tobacco products in consistent terms, and a report on India’ notoriously harmful indigenous smokeless tobacco products.
Tobacco Reporter’s November 2021 issue looks ahead at the ninth Conference of the Parties to the World Health Organization’s Framework Convention on Tobacco Control (COP9), which takes place Nov. 8-13.
The FCTC has attracted considerable criticism from tobacco harm reduction activists, who complain about a lack of transparency and mission creep. Instead of focusing on mortality reduction, as the treaty’s creators intended, the WHO is increasingly pursuing a counterproductive war on nicotine, according to commentators.
We also reflect on another though-provoking Global Tobacco & Nicotine Forum. After last virtual forum, we were pleased to welcome delegates both in person and online this year.
Also in this issue: The latest on the U.S. market as the Food and Drug Administration issues its first-ever marketing orders for an electronic nicotine delivery system and backtracks on some marketing denial orders; and a profile of Hall Analytical, which expects its nicotine business to increase significantly over the next five years.
Tobacco Reporter’s October 2021 examines at the aftermath of Sept. 9, the day on which the Food and Drug Administration ordered the removal of hundreds of thousands electronic nicotine delivery systems from the U.S. market. What are the industry’s options in the wake of that development, and what about the bestselling products still under review?
Cheryl Olsen highlights a landmark article by nicotine experts that provides a rare balanced look a vaping in the U.S. George Gay evaluates the outlook for tobacco machinery and reconstituted tobacco in a rapidly changing environment and Stefanie Rossel takes a look at the Philippines, which has courageously rejected attempts by well-funded special interested groups to influence its tobacco-control policies.
Also in this issue: The trials and tribulations of the global paper industry, which has been wrestling with rapidly rising cost for raw materials, energy and transportation.
In Tobacco Reporter’s September 2021 issue, Clive Bates explores sustainability, strategy and survival in the tobacco market as the industry prepares for the GTNF on Sept. 21-23. As it tuns out, there’s a lot more to sustainability than corporate social responsibility.
BAT’s director of scientific research, David O’Reilly, explains why making tobacco harm reduction a reality is more important than ever, and Cheryl Olsen reveals what industry scientists wish they could say to physicians and public health researchers about their work.
George Gay details the recent rebranding of Republic Brands and Stefanie Rossel takes the industry’s pulse as the U.S. Food and Drug Administration nears its deadline to decide on millions of tobacco marketing applications.
Tobacco Reporter’s August 2021 issue highlights Cas-CLOVER, a new genetic editing technology to help reduce nicotine levels in tobacco. If the U.S. Food and Drug Administration’s proposal to mandate ‘minimally addictive’ levels of the stimulant in tobacco products comes to fruition, cigarette companies will have to radically redesign their products. Cas-Clover will be yet another tool available to help them in that process.
Coresta Secretary General Stephane Colard offers suggestions how the tobacco industry can demonstrate its responsible approach to a skeptical audience, and Reynold’s executive vice president of research and development, James Murphy, discusses the challenges and opportunities for tobacco harm reduction.
Also in this issue: The makeover of the venerable Rizla brand, which traces its history to Napoleonic times, and an update on the crusade against menthol cigarettes, which is showing no signs of letting up.
Tobacco Reporter’s July 2021 issue examines the global leaf trade as it emerges from the Covid-19 crisis. Characterized by personal interactions and heavily dependent on logistics, the sector was hit hard by the pandemic.
Yet, remarkably, the leaf market this year has emerged from the gates “sizzling hot,” in the words of one merchant.
We highlight the results of a recent long-term, randomized, controlled trial of BAT’s glo tobacco-heating product, which lends credibility to the harm reduction potential of the entire category.
Stefanie Rossel interviews ATD’s new CEO, Koen te Lintelo, about cigar machinery and George Gay details KT&G’s efforts to stay ahead of its rivals in both combustible cigarettes and tobacco-heating products.
Tobacco Reporter’s June 2021 issue explores what might happen if Chinese regulators move forward with their proposal to regulate vapor products like tobacco.
The domestic vapor industry’s meteoric rise has been driven by the visions of individual entrepreneurs and facilitated by the government’s comparatively light touch. The Chinese tobacco industry by contrast is characterized by officials fulfilling centrally set production targets. Unsurprisingly, investors are following the debate closely.
Also in this issue, Stefanie Rossel reports from the debut In Focus: Harm Reduction virtual conference and George Gay speaks with representatives of Alliance One International. Despite stagnating cigarette volumes, the leaf merchant believes there is opportunity for suppliers who can offer tobacco produced in a sustainable manner.
We also relate the remarkable story of Mayiwepi Jiti, who defied the odds to become a successful commercial tobacco grower in Zimbabwe’s male-dominated leaf industry.
Tobacco Reporter’s May 2021 edition details efforts to improve the lot of female tobacco farmers in Malawi. Women do much of the work on the farm but remain disadvantaged in many respects. Giving women more prominent roles is not only socially desirable, it should also help boosts the overall economy, according to experts.
Clive Bates presents a seven-point reform program for the World Health Organization and Cheryl Olsen explains how the tobacco companies’ past behavior continues to affect how regulators treat the industry today.
Tobacco Reporter’s April 2021 profiles the global tobacco logistics business: How has it fared amid the Covid-19-related disruptions?
Timothy Donahue examines the opportunities for the vapor business in China. With some 300 million smokers, the country should be a prime market for e-cigarettes, but government plans to regulate vapor like tobacco have darkened the outlook.
In Tobacco Reporter’s March 2021 issue, Clive Bates examines the remarkable resistance to electronic nicotine delivery devices in the public health establishment. While e-cigarettes and tobacco-heating products arguably represent a once-in-a-lifetime opportunity to reduce the health toll of smoking, they continue to encounter vehement opposition. What is going on?
Cheryl Olson and Willie McKinney share their insights into the U.S. Food and Drug Administration’s final rule on premarket tobacco product applications and George Gay draws parallels between the fight against illicit vapor products and that against illegal tobacco products. Can society avoid repeating past mistakes?
Stefanie Rossel relates how tobacco farmers in Colombia coped after two major customers pulled out of the country. Does their experience hold lessons for growers in other markets who face slumping demand for leaf?
In its February 2021 issue, Tobacco Reporter highlights the industry’s efforts to eradicate child labor, taking Indonesia as a case study to illustrate the challenges and opportunities in this fight.
Beth Oliva and Philip Langer of Roth Foxschild evaluate the progress that has been made since the U.S. Food and Drug Administration announced its comprehensive plan for tobacco and nicotine regulation in 2017.
Renowned public health researcher Cheryl Olsen sheds light on one what is arguably the most confusing part of a U.S. tobacco marketing application—the perception and intention study.
Also in this issue: An exclusive interview with the director of the Foundation for a Smoke-Free World, Derek Yach.
Tobacco Reporter’s January 2021 issue examines the plight of tobacco farmers in the Covid-19 crisis. How are they coping with the double whammy of a pandemic and declining demand for their products?
TMA President and CEO Chris Greer evaluates the outlook for the nicotine business in the wake of the recent U.S. elections and George Gay highlights efforts to make the harvesting and processing of oriental leaf tobacco more efficient.
Stefanie Rossels digs into the conflict of interest that arises when governments that have stakes in the tobacco industry sign on to a global treaty designed to reduce smoking.
In our December 2020 issue, Tobacco Reporter contributor Patricia Kovacevic draws on her extensive legal and regulatory expertise to speculate on the impact of America’s election outcome. What might a Biden administration might have in store for the nicotine business?
Stefanie Rossel reviews the most recent Burning Issues report to assess the global state of tobacco harm reduction and George Gay interviews Tobacco Technology’s George Cassels-Smith about the potential of synthetic nicotine.
We also highlight Hauni’s attempt to break into the cannabis market with new machinery designed specifically for hemp products.
Tobacco Reporter’s November 2020 issue takes a critical look at the World Health Organization Framework Convention on Tobacco Control, which celebrates its 15th anniversary this year. To what extent has the treaty succeeded in its stated aim of protecting the world from the health, social, environmental and economic consequences of tobacco consumption?
Clive Bates challenges what he views as the governing idea of tobacco control—that there is an irreconcilable conflict between the tobacco industry’s interests and public health interests.
And we look back at a very successful GTNF. The first virtual iteration attracted a record number of participants and featured some of the most stimulating debates yet on tobacco harm reduction, the future of nicotine and product innovation, among other topics.
In its October issue, Tobacco Reporter portrays some of British American Tobacco’s leading female scientists. What drives them? Who are their role models? And what do they consider to be the greatest challenges working in tobacco and science?
While the portraits that emerge are as a diverse as the scientists themselves, they collectively demonstrate the tremendous contributions that women can make to an organization—and how much companies that resist their participation lose out.
Tobacco Reporter’s September 2020 issue highlights the GTNF, which has moved online because of the enduring Covid-19 pandemic. Despite this year’s unprecedented environment, you can expect a first-rate event featuring an exceptional lineup of speakers and panelists, along with some innovative online features.
Also in this issue: the aftermath of last year’s EVALI crisis; a remarkable new technology to eliminate secondhand smoke; and an expert look at the requirements to keep your nicotine products on the U.S. markets after they have been authorized by the Food and Drug Administration.
Tobacco Reporter’s August 2020 issue highlights the industry’s last-minute scramble to submit pre-market tobacco product applications to the U.S. Food and Drug Administration ahead of the Sept. 9 deadline. What will the tobacco landscape look like after the due date? We examine the issue from a product viewpoint and a testing perspective.
The August issue further features the remarkably resilient cigar business, along with the roll-your-own and make-your-own segments, which serve as an important safety nets in times of economic headship.
Also in this issue: A profile of one of the industry’s leading data providers, Management Science Associates.
Tobacco Reporter’s July 2020 issue profiles KT&G of South Korea, which operates in one of the world’s most sophisticated tobacco markets.
KT&G has traditionally kept a low profile, but it’s a world-class operation with grand ambitions that could very well become one of the world’s top four cigarette manufacturers within the next few years.
Also in this issue: how leaf manufacturers are rethinking their business in the wake of the coronavirus pandemic, a look at the world’s most prominent heat-not-burn markets and an examination of the nicotine pouch phenomenon that has caught the world by storm.
In its June 2020 issue, Tobacco Reporter examines the industry’s remarkable efforts to develop a Covid-19 vaccine.
While using a plant widely associated with respiratory diseases to help tackle the coronavirus pandemic may strike some as odd, there are sound scientific reasons for pursuing this route.
Clive Bates investigates reports that nicotine may protect against Covid-19. As it turns out, there may be more to the findings than tobacco’s detractors would like the public to believe.
Also in this issue: A look at how the coronavirus has impacted tobacco farmers and a review of alternatives for smokers following the EU ban on menthol cigarettes.
Tobacco Reporter’s May 2020 issue further explores the ongoing disruption to the nicotine business brought about by the coronavirus crisis.
Will the industry live up to its reputation as a haven in times of crisis or will it be overwhelmed by the sheer scale of the pandemic?
Also in this issue: The new deadline for submitting premarket tobacco product applications, British American Tobacco’s preparations for a radically different future and a look at e-cigarettes in India after that country banned vapor products.
The coronavirus has caused the greatest economic disruption of a generation.
In its April 2020 issue, Tobacco Reporter examines the impact to the tobacco and vapor industries, and speculates on what business as usual might look like after the pandemic passes.
Also in this issue: the challenge of recycling vapor product waste and suggestions to minimize the environmental impact of tobacco packaging.
In Tobacco Reporter’s March 2020, Clive Bates of The Counterfactual evaluates the impact of Brexit on the tobacco and vapor industries.
ITG Brands’ Gerald Long explains why HPHC testing is an unsuitable comparative measure for premium cigars, and Coresta’s new secretary-general, Stephane Colard, reveals his vision for the organization.
Following the considerable excitement in the wake of legalization and countless investments, some are now wondering whether the cannabis market has fallen victim to irrational exuberance.
In Tobacco Reporter’s February 2020 issue, a leading analyst suggests that the narrative remains intact and suggests investors take a long view.
Also in this issue: JTI’s efforts to reposition itself for a changing business, Malaysia’s struggle with illicit trade and the market for primary equipment.
In Tobacco Reporter’s January 2020 issue, Clive Bates examines the debates surrounding the U.S. outbreak of vaping-related illness and increase in youth vaping, in which facts have often been drowned out by falsehoods.
Stefanie Rossel contrasts the EU relative tolerance to vaping to its harsh treatment of snus while George Gay reports on Imperial Brands’ ambition to offer smokers “something better” than cigarettes.
Tobacco Reporter’s December 2019 issue reflects on health authorities’ response to the recent U.S. vaping scare.
By hesitating to acknowledge that the deaths and hospitalizations were to blame on black market products, they have inadvertently set back the potential of vapor products to help reduce the harm to health associated with tobacco consumption.
We also examine the market for synthetic nicotine and place into context the FDA’s approval of Swedish Match’s modified-risk tobacco product application for General snus.
Tobacco Reporter’s November 2019 issue looks back at the recent Global Tobacco & Nicotine Forum (GTNF) in Washington, D.C., which was arguably the most inspiring GTNF to date.
Featuring an unrivaled lineup of speakers, participants discussed the challenges facing the nicotine business and the opportunities that continue to exist.
We also examine the plight of the nicotine flavoring business considering the current controversy around youth consumption and the associated mounting restrictions.
Tobacco Reporter’s October 2019 issue focuses on the recent vape scare in the United States.
How will the measures contemplated against the industry in the wake of vaping-related deaths and hospitalizations impact the fledgling vapor business, even as most incidents appears to be linked to the consumption of illicit substances?
On a more upbeat note, we celebrate the 25th anniversary of the illustrious TABEXPO trade fair and congress, which debuted in Vienna in 1994 and reconvenes in Amsterdam Nov. 12–14.
In Tobacco Reporter’s September 2019 issue, Clive Bates refutes the often-heard argument that vaping should be restricted because there are no long-term risk assessments available.
Bates argues that stifling the development of potentially lower risk products presents a greater risk to public health than tolerating new technologies even with incomplete knowledge.
Stefanie Rossel examines China’s vapor industry regulatory initiatives, and we profile two service providers specialized in helping the industry comply with pharmaceutical-style requirements.
In Tobacco Reporter’s August 2019 issue, we look at the experience with harm reduction in areas such as narcotics and HIV.
How are the lessons learned there applicable to tobacco?
We examine the latest innovations in roll-your-own and make-your-own and report on the anniversary celebrations from two prominent tobacco-related organizations: the smokers’ rights group Forest and the Worshipful Company of Tobacco Pipe Makers and Tobacco Blenders.
Tobacco Reporter’s July 2019 issue examines the work of free-market think tanks, some of which have been criticized for accepting tobacco industry funding. To what extent does funding influence the research done and positions taken by these institutions?
Stefanie Rossel looks at the South Korean market where government policies have prevented next-generation products from living up to their full potential as tobacco harm reduction tools.
Also in this issue is a report on the U.S. smokeless market, which has been in thrall of new nicotine pouch products.
In Tobacco Reporter’s June 2019 issue, Clive Bates reveals the best alternative nicotine product to cigarettes.
Stefanie Rossel delves into a remarkable new business venture by Philip Morris International—the life insurance business.
George Gay reports from the U.K. Vaping Industry Association’s recent discussion forum and Timothy S. Donahue shares his impression from his recent visit to Shenzhen, China, where vapor hardware manufacturers are working feverishly to ensure their products meet the highest safety standards.
Tobacco Reporter’s May 2019 issue looks at how tobacco companies and other U.K. businesses are preparing for life after Brexit.
We take stock of the damage done by Tropical Cyclone Idai in southern Africa—one of the world’s leading tobacco-growing regions—and highlight the industry’s efforts to reduce the environmental impact of its products.
In Tobacco Reporter’s April 2019 issue, Patrick Basham examines the legacy of U.S. Food & Drug Administration Commissioner Scott Gottlieb.
Initially hailed as a pragmatist, Gottlieb cracked down on the vapor industry following an uptick in youth consumption.
We also look at various ways in which tobacco and vapor companies are working to minimize the environmental impact of their products. Timothy S. Donahue reports from the Habanos Festival in Cuba.